有机化学 ›› 2023, Vol. 43 ›› Issue (7): 2561-2566.DOI: 10.6023/cjoc202301012 上一篇    下一篇

研究简报

金核霉素生物合成途径的体内研究和关键代谢物鉴定

王飞a, 金文兵b, 侯现锋b, 唐功利a,b,*(), 潘海学a,b,*()   

  1. a国科大杭州高等研究院化学与材料科学学院 杭州 310024
    b中国科学院上海有机化学研究所 上海 200032
  • 收稿日期:2022-11-11 修回日期:2023-02-24 发布日期:2023-03-17
  • 通讯作者: 唐功利, 潘海学
  • 基金资助:
    国家自然科学基金(32070065)

In vivo Studies on the Biosynthetic Pathway of Aureonuclemycin and Identification of Key Metabolites

Fei Wanga, Wenbing Jinb, Xianfeng Houb, Gongli Tanga,b(), Haixue Pana,b()   

  1. aSchool of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024
    bShanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032
  • Received:2022-11-11 Revised:2023-02-24 Published:2023-03-17
  • Contact: Gongli Tang, Haixue Pan
  • Supported by:
    National Natural Science Foundation of China(32070065)

在前期获得金核霉素生物合成基因簇的基础上, 通过同框删除方法构建了全部基因敲除突变株, 确定了在金核霉素生物合成中发挥作用的关键基因. 通过突变株和野生型菌株发酵, 得到了两个关键的金核霉素类化合物. 根据体内基因敲除实验、突变株代谢物分析、关键化合物鉴定结果, 提出了金核霉素可能的生物合成途径.

关键词: 核苷类抗生素, 生物合成, 金核霉素

On the basis of aureonuclemycin biosynthetic gene cluster obtained in the previous work, in-frame markerless deletion mutants of all genes were constructed, and the key genes that play a role in the biosynthesis of aureonuclemycin were identified. Two key aureonuclemycin-like compounds were successfully obtained from mutant and wild-type strains. According to the results of in vivo experiments, metabolite analysis and identification of key compounds, the possible biosynthetic pathway of aureonuclemycin was proposed.

Key words: nucleoside antibiotic, biosynthesis, aureonuclemycin